Pivit provides an oral dietary supplement that uses a patented blend of six GRAS‑status food‑derived compounds to stimulate gut olfactory and taste receptors, triggering endogenous GLP‑1 release. The resulting increase in satiety hormones helps users curb appetite, manage blood‑sugar spikes, and achieve gradual weight loss without injections or prescription drugs. The product is sold direct‑to‑consumer via one‑time or subscription pricing.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals struggle to achieve sustainable weight loss and stable blood‑sugar levels because existing options are either prescription GLP‑1 drugs that require injections and carry side‑effect risks, or over‑the‑counter supplements lacking scientific validation. This gap leaves health‑conscious consumers without a safe, effective, non‑pharmaceutical way to curb appetite and regulate metabolism.
Solution
Pivit offers a dietary supplement that activates the body’s own GLP‑1 production by delivering a patented blend of naturally occurring food molecules. These compounds engage gut olfactory and taste receptors (e.g., OR51E1), prompting endogenous GLP‑1 release that signals satiety, moderates insulin secretion, and slows gastric emptying. Because the ingredients are Generally Recognized As Safe (GRAS) and derived from common spices and plant extracts, the formulation avoids synthetic hormones and associated adverse events. The product is administered orally, requires no injections, and is designed for continuous, long‑term metabolic support. Clinical‑grade research underpins the receptor‑targeted mechanism, positioning Pivit as a scientifically grounded alternative to pharmaceutical GLP‑1 agonists. Users experience reduced cravings, lower post‑prandial glucose spikes, and gradual, sustainable weight reduction without dependence on prescription medication.
Target Audience
The primary customers are health‑conscious adults seeking non‑prescription solutions for weight loss, appetite control, and blood‑sugar stability—particularly those who prefer natural, scientifically backed supplements over injectable pharmaceuticals.
Features
- Patented blend of six food‑derived ligands (cinnamaldehyde, lauric acid, benzyl acetate, eugenol, butyl‑butyryl lactate, spearmint oil) that selectively activate gut GPCRs linked to GLP‑1 secretion.
- Mechanistic action based on stimulation of ectopic olfactory and taste receptors (ORs/TRs) in the gastrointestinal tract, validated by in‑vitro studies showing increased GLP‑1 release.
- All ingredients hold FDA GRAS status, eliminating synthetic hormone exposure and minimizing side‑effect risk.
- Oral capsule format delivers consistent dosing without injections or medical supervision.
- Supports both weight‑management and blood‑sugar regulation through natural metabolic pathways.
- Free U.S. shipping (2‑5 days) with optional expedited delivery; subscription model ensures uninterrupted supply.
- Transparent pricing with a one‑time purchase option and a recurring subscription at a reduced rate.